BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35869530)

  • 1. Assessing the clinical utility of protein structural analysis in genomic variant classification: experiences from a diagnostic laboratory.
    Caswell RC; Gunning AC; Owens MM; Ellard S; Wright CF
    Genome Med; 2022 Jul; 14(1):77. PubMed ID: 35869530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
    Andreis TF; de Souza KIW; Vieira IA; Alemar B; Sinigaglia M; de Araújo Rocha YM; Artigalás O; Bittar C; Oliveira Netto CB; Ashton-Prolla P; Rosset C
    Gene; 2023 Apr; 862():147281. PubMed ID: 36775216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome.
    Bains S; Dotzler SM; Krijger C; Giudicessi JR; Ye D; Bikker H; Rohatgi RK; Tester DJ; Bos JM; Wilde AAM; Ackerman MJ
    Heart Rhythm; 2022 Mar; 19(3):435-442. PubMed ID: 34798354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.
    SoRelle JA; Thodeson DM; Arnold S; Gotway G; Park JY
    JAMA Pediatr; 2019 Jan; 173(1):e182302. PubMed ID: 30398534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Variant Analysis Tool: Analyzing the evidence supporting reported genomic variation in clinical practice.
    Chin HL; Gazzaz N; Huynh S; Handra I; Warnock L; Moller-Hansen A; Boerkoel P; Jacobsen JOB; du Souich C; Zhang N; Shefchek K; Prentice LM; Washington N; Haendel M; Armstrong L; Clarke L; Li WL; Smedley D; Robinson PN; Boerkoel CF
    Genet Med; 2022 Jul; 24(7):1512-1522. PubMed ID: 35442193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How human genetic context can inform pathogenicity classification: FGFR1 variation in idiopathic hypogonadotropic hypogonadism.
    Xu W; Plummer L; Seminara SB; Balasubramanian R; Lippincott MF
    Hum Genet; 2023 Nov; 142(11):1611-1619. PubMed ID: 37805574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance.
    Giudicessi JR; Lieve KVV; Rohatgi RK; Koca F; Tester DJ; van der Werf C; Martijn Bos J; Wilde AAM; Ackerman MJ
    Circ Genom Precis Med; 2019 May; 12(5):e002510. PubMed ID: 31112425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.
    Bennett JS; Bernhardt M; McBride KL; Reshmi SC; Zmuda E; Kertesz NJ; Garg V; Fitzgerald-Butt S; Kamp AN
    Pediatr Cardiol; 2019 Dec; 40(8):1679-1687. PubMed ID: 31535183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of a Phenotype-Enhanced
    Mattivi CL; Bos JM; Bagnall RD; Nowak N; Giudicessi JR; Ommen SR; Semsarian C; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):453-459. PubMed ID: 32894683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Variant Findings and Challenges Associated With the Clinical Integration of Genomic Testing: An Interim Report of the Genomic Medicine for Ill Neonates and Infants (GEMINI) Study.
    Maron JL; Kingsmore SF; Wigby K; Chowdhury S; Dimmock D; Poindexter B; Suhrie K; Vockley J; Diacovo T; Gelb BD; Stroustrup A; Powell CM; Trembath A; Gallen M; Mullen TE; Tanpaiboon P; Reed D; Kurfiss A; Davis JM
    JAMA Pediatr; 2021 May; 175(5):e205906. PubMed ID: 33587123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two Massive Open Online Courses (MOOCs) in genomic variant interpretation for the NHS workforce.
    Coad B; Joekes K; Rudnicka A; Frost A; Openshaw MR; Tatton-Brown K; Snape K
    BMC Med Educ; 2023 Jul; 23(1):540. PubMed ID: 37507729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessment of the NF1 variants of unknown significance found during the 20-year activity of a genetics diagnostic laboratory.
    Martorana D; Barili V; Uliana V; Ambrosini E; Riva M; De Sensi E; Luppi E; Messina C; Caleffi E; Pisani F; Percesepe A
    Eur J Med Genet; 2023 Nov; 66(11):104847. PubMed ID: 37751797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A machine learning approach based on ACMG/AMP guidelines for genomic variant classification and prioritization.
    Nicora G; Zucca S; Limongelli I; Bellazzi R; Magni P
    Sci Rep; 2022 Feb; 12(1):2517. PubMed ID: 35169226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA variant classification-reconsidering "allele rarity" and "phenotype" criteria in ACMG/AMP guidelines.
    Davieson CD; Joyce KE; Sharma L; Shovlin CL
    Eur J Med Genet; 2021 Oct; 64(10):104312. PubMed ID: 34411772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance.
    Lyra PCM; Nepomuceno TC; de Souza MLM; Machado GF; Veloso MF; Henriques TB; Dos Santos DZ; Ribeiro IG; Ribeiro RS; Rangel LBA; Richardson M; Iversen ES; Goldgar D; Couch FJ; Carvalho MA; Monteiro ANA
    Genet Med; 2021 Feb; 23(2):306-315. PubMed ID: 33087888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Thermodynamic Destabilization in the Assessment of Pathogenicity of a Variant of Uncertain Significance in Cardiac Myosin Binding Protein C.
    Pricolo MR; Herrero-Galán E; Mazzaccara C; Losi MA; Alegre-Cebollada J; Frisso G
    J Cardiovasc Transl Res; 2020 Oct; 13(5):867-877. PubMed ID: 32034629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preimplantation genetic testing (PGT) for copy number variants of uncertain significance (CNV- VUS) in the genomic era: to do or not to do?
    Rotshenker-Olshinka K; Srebnik Moshe N; Weiss O; Shaviv S; Freireich O; Segel R; Zeligson S; Eldar-Geva T; Altarescu G
    J Assist Reprod Genet; 2021 Mar; 38(3):719-725. PubMed ID: 33443723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 variants of uncertain significance: increasing challenges in variant interpretation and genetic counseling.
    Bittar CM; Vieira IA; Sabato CS; Andreis TF; Alemar B; Artigalás O; Galvão HCR; Macedo GS; Palmero EI; Ashton-Prolla P
    Fam Cancer; 2019 Oct; 18(4):451-456. PubMed ID: 31321604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.